Tonix Pharmaceuticals Holding (TNXP) Cash & Current Investments: 2023-2025
Historic Cash & Current Investments for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Sep 2025 value amounting to $190.1 million.
- Tonix Pharmaceuticals Holding's Cash & Current Investments rose 573.17% to $190.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $545.9 million, marking a year-over-year increase of 747.82%. This contributed to the annual value of $98.8 million for FY2024, which is 295.93% up from last year.
- Per Tonix Pharmaceuticals Holding's latest filing, its Cash & Current Investments stood at $190.1 million for Q3 2025, which was up 51.64% from $125.3 million recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Cash & Current Investments ranged from a high of $190.1 million in Q3 2025 and a low of $4.2 million during Q2 2024.
- In the last 3 years, Tonix Pharmaceuticals Holding's Cash & Current Investments had a median value of $28.2 million in 2024 and averaged $65.0 million.
- Its Cash & Current Investments has fluctuated over the past 5 years, first plummeted by 90.21% in 2024, then spiked by 2,915.66% in 2025.
- Tonix Pharmaceuticals Holding's Cash & Current Investments (Quarterly) stood at $24.9 million in 2023, then surged by 295.93% to $98.8 million in 2024, then spiked by 573.17% to $190.1 million in 2025.
- Its Cash & Current Investments was $190.1 million in Q3 2025, compared to $125.3 million in Q2 2025 and $131.7 million in Q1 2025.